Primary haemostasis: Newer insights

Haemophilia

Volumn 20, Issue S4, 2014, Pages 15-22

  Berndt, M C ^a   Metharom, P ^a   Andrews, R K ^b  

^a CURTIN UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Arterial thrombosis; Clec 2; Glycoprotein Ib; Glycoptrotein VI; Venous thrombosis; Von Willebrand factor

Indexed keywords

COLLAGEN; GLYCOPROTEIN IB ALPHA; LIGAND; THROMBOCYTE RECEPTOR; VON WILLEBRAND FACTOR; ADHESION RECEPTOR; GLYCOCALICIN; PROTEIN BINDING; THROMBIN RECEPTOR;

BLOOD CLOTTING; CELL INTERACTION; HEMOSTASIS; HUMAN; NONHUMAN; PRIMARY HAEMOSTASIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; ANIMAL; CELL COMMUNICATION; LEUKOCYTE; METABOLISM; PHYSIOLOGY; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; CELL COMMUNICATION; HEMOSTASIS; HUMANS; LEUKOCYTES; LIGANDS; PLATELET ADHESIVENESS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 84899580394     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12427     Document Type: Review

References (91)

1. Barkhan P, Silver MJ, Da Costa PB, Tocantins LM. Phosphatidyl serine and blood coagulation. Nature 1958; 182: 1031-2.
2. Jackson SP. Arterial thrombosis-insidious, unpredictable and deadly. Nat Med 2011; 17: 1423-36.
3. Versteeg HH, Heemskerk JWM, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev 2013; 93: 327-58.
4. Andrews RK, Berndt MC. Platelet physiology and thrombosis. Thromb Res 2004; 114: 447-53.
5. Rondina MT, Weyrich AS, Zimmerman GA. Platelets as cellular effectors of inflammation in vascular diseases. Circ Res 2013; 112: 1506-19.
6. Ware J, Corken A, Khetpal R. Platelet function beyond hemostasis and thrombosis. Curr Opin Hematol 2013; 20: 451-6.
7. Speth C, Löffler J, Krappmann S, Lass-Flörl C, Rambach G. Platelets as immune cells in infectious diseases. Future Microbiol 2013; 8: 1431-51.
8. Gardiner EE, Andrews RK. Platelets: envoys at the infection frontline. J Infect Dis 2013; 208: 871-3.
9. Wong CH, Jenne CN, Petri B, Chrobok NL, Kubes P. Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat Immunol 2013; 14: 785-92.
10. Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood 1996; 88: 1525-41.
11. Cosemans JM, Angelillo-Scherrer A, Mattheij NJ, Heemskerk JW. The effects of arterial flow on platelet activation, thrombus growth, and stabilization. Cardiovasc Res 2013; 99: 342-52.
12. Andrews RK, Karunakaran D, Gardiner EE, Berndt MC. Platelet receptor shedding: a mechanism for downregulating platelet reactivity. Arterioscler Thromb Vasc Biol 2007; 27: 1511-20.
13. García A, Zitzmann N, Watson SP. Analyzing the platelet proteome. Semin Thromb Hemost 2004; 30: 485-9.
14. García A, Prabhakar S, Brock CJ et al. Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 2004; 4: 656-68.
15. Burkhart JM, Vaudel M, Gambaryan S et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 2012; 120: e73-82.
16. O'Neill EE, Brock CJ, von Kriegsheim AF et al. Towards complete analysis of the platelet proteome. Proteomics 2002; 2: 288-305.
17. Senzel L, Gnatenko DV, Bahou WF. The platelet proteome. Curr Opin Hematol 2009; 16: 329-33.
18. Watson SP, Bahou WF, Fitzgerald D, Ouwehand W, Rao AK, Leavitt AD. ISTH Platelet Physiology Subcommittee. Mapping the platelet proteome: a report of the ISTH Platelet Physiology Subcommittee. J Thromb Haemost 2005; 3: 2098-101.
19. Fong KP, Barry C, Tran AN et al. Deciphering the human platelet sheddome. Blood 2011; 117: e15-26.
20. Andrews RK, Berndt MC. The glycoprotein Ib-IX-V complex. In: Platelets (3rd edition). A Michelson (ed), Academic Press, San Diego, 2012; 10: 195-214.
21. Han BW, Herrin BR, Cooper MD, Wilson IA. Antigen recognition by variable lymphocyte receptors. Science 2008; 321: 1834-7.
22. Romo GM, Dong JF, Schade AJ et al. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med 1999; 190: 803-14.
23. Simon DI, Chen Z, Xu H et al. Platelet glycoprotein Ibα is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 2000; 192: 193-204.
24. Andrews RK, Berndt MC, Elalamy I. Platelets: from function to dysfunction in essential thrombocythaemia. Eur Haematol Oncol 2011; 7: 125-31.
25. Gardiner EE, Andrews RK. Structure and function of platelet receptors initiating blood clotting. In: A Systems Biology Approach to Hematology. S Corey, M. Kimmel (eds), Springer, New York, 2014; in press.
26. Stockschlaeder M, Schneppenheim R, Budde U. Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis. Blood Coagul Fibrinolysis [Epub ahead of print]. doi: 10.1097/MBC.0000000000000065.
27. Wagner DD. Cell biology of von Willebrand factor. Annu Rev Cell Biol 1990; 6: 217-46.
28. Padilla A, Moake JL, Bernardo A et al. P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface. Blood 2004; 103: 2150-6.
29. Schaff M, Tang C, Maurer E et al. Integrin α6β1 is the main receptor for vascular laminins and plays a role in platelet adhesion, activation, and arterial thrombosis. Circulation 2013; 128: 541-52.
30. Andrews RK, Gorman JJ, Booth WJ, Corino GL, Castaldi PA, Berndt MC. Cross-linking of a monomeric 39/34-kDa fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the α-chain of membrane glycoprotein Ib on intact platelets with bis(sulfosuccinimidyl) suberate. Biochemistry 1989; 28: 8326-36.
31. Yago T, Lou J, Wu T et al. Platelet glycoprotein Ibα forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. J Clin Invest 2008; 118: 3195-207.
32. Blenner MA, Dong X, Springer TA. Towards the structural basis of regulation of von Willebrand factor binding to glycoprotein Ib. J Biol Chem 2014; 289: 5565-79.
33. Sadler JE. New concepts in von Willebrand disease. Ann Rev Med 2005; 56: 173-91.
34. Arthur JF, Matzaris M, Gardiner EE et al. Glycoprotein (GP)VI is associated with GPIb-IX-V on the membrane of resting and activated platelets. Thromb Haemostas 2005; 93: 716-23.
35. Gardiner EE, Arthur JF, Shen Y et al. GPIbα-selective activation of platelets induces platelet signalling events comparable to GPVI activation events. Platelets 2010; 21: 244-52.
36. Moog S, Mangin P, Lenain N et al. Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation. Blood 2001; 98: 1038-46.
37. Ozaki Y, Suzuki-Inoue K, Inoue O. Platelet receptors activated via mulitmerization: glycoprotein VI, GPIb-IX-V, and CLEC-2. J Thromb Haemost 2013; 11(Suppl 1): 330-9.
38. Zahid M, Mangin P, Loyau S et al. The future of glycoprotein VI as an antithrombotic target. J Thromb Haemost 2012; 10: 2418-27.
39. Dütting S, Bender M, Nieswandt B. Platelet GPVI: a target for antithrombotic therapy?!. Trends Pharmacol Sci 2012; 33: 583-90.
40. Bergmeier W, Stefanini L. Platelet ITAM signaling. Curr Opin Hematol 2013; 20: 445-50.
41. Arthur JF, Gardiner EE, Kenny D, Andrews RK, Berndt MC. Platelet receptor redox regulation. Platelets 2008; 19: 1-8.
42. Arthur JF, Shen Y, Gardiner EE et al. TNF Receptor-Associated Factor 4 (TRAF4) is a novel binding partner of glycoprotein Ib and glycoprotein VI in human platelets. J Thromb Haemostas 2011; 9: 163-72.
43. Arthur JF, Qiao J, Shen Y et al. ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and -independent pathways. J Thromb Haemost 2012; 10: 1133-41.
44. Vara D, Campanella M, Pula G. The novel NOX inhibitor 2-acetylphenothiazine impairs collagen-dependent thrombus formation in a GPVI-dependent manner. Br J Pharmacol 2013; 168: 212-24.
45. Arthur JF, Shen Y, Chen Y et al. Exacerbation of GPVI-dependent platelet responses in a rhesus monkey model of type 1 diabetes. J Diabetes Res 2013; 2013: 370212.
46. Walsh TG, Berndt MC, Carrim N, Cowman J, Kenny D, Metharom P. The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus formation. Redox Biol 2014; 2: 178-86.
47. Bender M, May F, Lorenz V et al. Combined in vivo depletion of glycoprotein VI and C-type lectin-like receptor 2 severely compromises hemostasis and abrogates arterial thrombosis in mice. Arterioscler Thromb Vasc Biol 2013; 33: 926-34.
48. Dütting S, Vögtle T, Morowski M et al. Growth factor receptor-bound protein 2 contributes to (hem)immunoreceptor tyrosine-based activation motif-mediated signaling in platelets. Circ Res 2014; 114: 444-53.
49. Berndt MC, Andrews RK. Platelet (hem)ITAM receptors: at least one required. Arterioscler Thromb Vasc Biol 2013; 33: 884-5.
50. Sullam PM, Hyun WC, Szöllösi J, Dong JF, Foss WM, López JA. Physical proximity and functional interplay of the glycoprotein Ib-IX-V complex and the Fc receptor FcγRIIA on the platelet plasma membrane. J Biol Chem 1998; 273: 5331-6.
51. Gardiner EE, Karunakaran D, Arthur JF et al. Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: De-ITAM-ising FcγRIIa. Blood 2008; 111: 165-74.
52. Deppermann C, Cherpokova D, Nurden P et al. Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice. J Clin Invest 2013; 123: 3331-42.
53. Gong H, Shen B, Flevaris P et al. G protein subunit Gα13 binds to integrin αIIbβ3 and mediates integrin "outside-in" signaling. Science 2010; 327: 340-3.
54. Shen B, Zhao X, O'Brien KA et al. A directional switch of integrin signalling and a new anti-thrombotic strategy. Nature 2013; 503: 131-5.
55. Wang L, Wu Y, Zhou J et al. Platelet-derived ERp57 mediates platelet incorporation into a growing thrombus by regulation of the αIIbβ3 integrin. Blood 2013; 122: 3642-50.
56. Gardiner EE, Karunakaran D, Shen Y, Andrews RK, Berndt MC. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemostas 2007; 5: 1530-7.
57. Al-Tamimi M, Grigoriadis G, Tran H et al. Coagulation-induced shedding of platelet glycoprotein VI mediated by Factor Xa. Blood 2011; 117: 3912-20.
58. Al-Tamimi M, Tan CW, Qiao J et al. Pathological shear triggers shedding of vascular receptors: a novel mechanism for downregulation of platelet glycoprotein (GP)VI in stenosed coronary vessels. Blood 2012; 119: 4311-20.
59. Bender M, Hofmann S, Stegner D et al. Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases. Blood 2010; 116: 3347-55.
60. Bergmeier W, Piffath CL, Cheng G et al. Tumor necrosis factor-α-converting enzyme (ADAM17) mediates GPIbα shedding from platelets in vitro and in vivo. Circ Res 2004; 95: 677-83.
61. Rabie T, Strehl A, Ludwig A, Nieswandt B. Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J Biol Chem 2005; 280: 14462-8.
62. Azorsa DO, Moog S, Ravanat C et al. Measurement of GPV released by activated platelets using a sensitive immunocapture ELISA - its use to follow platelet storage in transfusion. Thromb Haemost 1999; 81: 131-8.
63. Ravanat C, Freund M, Mangin P et al. GPV is a marker of in vivo platelet activation - study in a rat thrombosis model. Thromb Haemost 2000; 83: 327-33.
64. Duerschmied D, Canault M, Lievens D et al. Serotonin stimulates platelet receptor shedding by tumor necrosis factor-α-converting enzyme (ADAM17). J Thromb Haemost 2009; 7: 1163-71.
65. Brill A, Chauhan AK, Canault M, Walsh MT, Bergmeier W, Wagner DD. Oxidative stress activates ADAM17/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion. Cardiovasc Res 2009; 84: 137-44.
66. Cheng H, Yan R, Li S et al. Shear-induced interaction of platelets with von Willebrand factor results in glycoprotein Ibα shedding. Am J Physiol Heart Circ Physiol 2009; 297: H2128-35.
67. van der Wal DE, Gitz E, Du VX et al. Arachidonic acid depletion extends survival of cold-stored platelets by interfering with the [glycoprotein Ibα-14-3-3ζ] association. Haematologica 2012; 97: 1514-22.
68. Yuan Y, Zhang W, Yan R et al. Identification of a novel 14-3-3ζ binding site within the cytoplasmic domain of platelet glycoprotein Ibα that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX. Circ Res 2009; 105: 1177-85.
69. Best D, Senis YA, Jarvis GE et al. GPVI levels in platelets: relationship to platelet function at high shear. Blood 2003; 102: 2811-8.
70. Fredrickson BJ, Dong JF, McIntire LV, López JA. Shear-dependent rolling on von Willebrand factor of mammalian cells expressing the platelet glycoprotein Ib-IX-V complex. Blood 1998; 92: 3684-93.
71. Kruss S, Erpenbeck L, Amschler K et al. Adhesion maturation of neutrophils on nanoscopically presented platelet receptor GPIbα. ACS Nano 2013; 7: 9984-96.
72. Rumjantseva V, Grewal PK, Wandall HH et al. Dual roles for hepatic lectin receptors in the clearance of chilled platelets. Nat Med 2009; 15: 1273-80.
73. Jansen AJG, Josefsson EC, Rumjantseva V et al. Desialylation accelerates platelet clearance after refrigeration and initiates GPIbα metalloproteinase-mediated cleavage in mice. Blood 2012; 119: 1263-73.
74. Brinkmann V, Reichard U, Goosmann C et al. Neutrophil extracellular traps kill bacteria. Science 2004; 303: 1532-5.
75. Martinod K, Wagner DD. Thrombosis: tangled up in NETs. Blood [Epub ahead of print]. doi:10.1182/blood-2013-10-463646.
76. Page C, Pitchford S. Neutrophil and platelet complexes and their relevance to neutrophil recruitment and activation. Int Immunopharmacol 2013; 117: 1176-84.
77. Gardiner EE, Andrews RK. Neutrophil extracellular traps (NETs) and infection-related vascular dysfunction. Blood Rev 2012; 26: 255-9.
78. Gardiner EE, Ward CM, Andrews RK. The NET effect of clot formation. J Thromb Haemostas 2012; 10: 133-5.
79. Jenne CN, Urrutia R, Kubes P. Platelets: bridging hemostasis, inflammation, and immunity. Int J Lab Hematol 2013; 35: 254-61.
80. Clark SR, Ma AC, Tavener SA et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007; 13: 463-9.
81. Caudrillier A, Kessenbrock K, Gilliss BM et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 2012; 122: 2661-71.
82. Martinod K, Demers M, Fuchs TA et al. Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. Proc Natl Acad Sci USA 2013; 110: 8674-9.
83. Demers M, Krause DS, Schatzberg D et al. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci USA 2012; 109: 13076-81.
84. Ward CM, Tetaz TJ, Andrews RK, Berndt MC. Binding of the von Willebrand factor A1 domain to histone. Thromb Res 1997; 86: 469-77.
85. Fuchs TA, Brill A, Duerschmied D et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA 2010; 107: 15880-5.
86. von Bruhl ML, Stark K, Steinhart A et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012; 209: 819-35.
87. Brill A, Fuchs TA, Savchenko AS et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost 2012; 10: 136-44.
88. Brill A, Fuchs TA, Chauhan AK et al. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood 2011; 117: 1400-7.
89. Diaz JA, Fuchs TA, Jackson TO et al. Plasma DNA is elevated in patients with deep vein thrombosis. J Vasc Surg Venous Lymphat Disord 2013; 1: 1.
90. Arthur JF, Dunkley S, Andrews RK. Platelet glycoprotein VI-related clinical defects. Br J Haematol 2007; 139: 363-72.
91. Boulaftali Y, Hess PR, Getz TM et al. Platelet ITAM signaling is critical for vascular integrity in inflammation. J Clin Invest 2013; 123: 908-16.